S&P 500
(0.06%) 5 476.77 points
Dow Jones
(0.00%) 38 778 points
Nasdaq
(0.06%) 17 868 points
Oil
(0.27%) $80.55
Gas
(0.86%) $2.81
Gold
(0.14%) $2 332.20
Silver
(-0.29%) $29.31
Platinum
(-0.10%) $969.90
USD/EUR
(0.02%) $0.932
USD/NOK
(-0.17%) $10.64
USD/GBP
(0.05%) $0.788
USD/RUB
(-1.87%) $86.80

Realaus laiko atnaujinimai Lisata Therapeutics, Inc. [LSTA]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Biotechnology
Atnaujinta17 birž. 2024 @ 23:00

-4.97% $ 3.44

Live Chart Being Loaded With Signals

Commentary (17 birž. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by 0.00% compare to its pairs and should correct downwards.

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue...

Stats
Šios dienos apimtis 17 134
Vidutinė apimtis 16 782
Rinkos kapitalizacija 28.58M
EPS $-0.650 ( Q1 | 2024-05-09 )
Kita pelno data ( $-0.750 ) 2024-08-12
Last Dividend $0.310 ( 2013-10-28 )
Next Dividend $0 ( N/A )
P/E -1.400
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0560 (1.63%)
AADI 0.00%
ABCL 0.98%
ABCM 0.04%
ABEO 0.22%
ABIO 2.17%
ABOS -0.40%
ABSI -0.44%
ABUS 0.33%
ABVX -0.22%
ACAD 0.84%
ACER -17.95%
ACET 0.38%
ACGN 1.29%
ACHL -2.44%
ACHV 1.63%
ACIU 0.00%
ACLX 0.28%
ACRV 0.73%
ACST 0.62%
ACXP 1.68%
ADAG -5.64%
ADAP -0.92%
ADGI 0.87%
ADIL -1.57%
ADMA 0.34%
ADPT -0.64%
ADTX -1.27%
ADVM -0.07%
ADXN -6.11%
AEON 11.51%
AEZS -5.44%
AFMD -0.59%
AGEN -4.34%
AGIO 0.56%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW 53.45%
AKBA -0.95%
AKRO 0.26%
AKTX -2.70%
AKUS 0.00%
ALBO 0.00%
ALDX 1.35%
ALEC -0.55%
ALGS -0.25%
ALKS 0.44%
ALLK -0.85%
ALLO -0.73%
ALLR -1.46%
ALNA 3.16%
ALNY -0.32%
ALPN 0.00%
ALPX 0.00%
ALRN -0.31%
ALT -1.18%
ALVR 0.60%
ALXN 0.00%
ALXO -1.49%
ALZN 0.00%
AMRN -0.52%
AMTI -3.13%
ANAB -0.94%
ANEB -5.58%
ANGN 0.00%
ANIX -1.15%
ANL 0.61%
ANNX -0.19%
ANPC -3.15%
APGE 0.36%
APGN 8.48%
APGNW 30.65%
APLM 8.82%
APLS -0.05%
APLT 0.21%
APM 1.33%
APOP 0.38%
APRE 2.44%
APTO 0.68%
APTX 3.17%
APVO -0.02%
ARAV -13.39%
ARCT -0.77%
ARDS 20.48%
ARDX -0.64%
ARGX 0.60%
ARNA 0.00%
ARPO -0.90%
ARQT -1.01%
ARTL -4.55%
ARTLW 9.80%
ARVN -0.60%
ARWR -0.44%
ASLN 2.75%
ASMB -0.86%
ASND 0.00%
ATAI 0.37%
ATHA -0.38%
ATHE -1.61%
ATHX -33.50%
ATNF -4.37%
ATOS 0.87%
ATRA -2.10%
ATXI -1.66%
ATXS 0.45%
AUPH -0.36%
AURA 0.68%
AUTL -0.23%
AVBP -0.27%
AVEO 0.00%
AVIR -0.42%
AVRO -2.05%
AVTE -3.04%
AVTX 4.15%
AVXL 0.13%
AXLA 0.00%
AXSM 0.07%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -0.29%
BCAB 1.92%
BCDA -0.30%
BCDAW -33.33%
BCEL -1.32%
BCLI -0.73%
BCRX -1.44%
BCTX -0.68%
BCTXW 0.00%
BCYC 1.49%
BDRX 0.06%
BDTX -0.55%
BEAM -0.12%
BFRA -2.91%
BGNE -1.47%
BIOR 0.03%
BIVI 1.73%
BLCM -6.68%
BLI -5.88%
BLPH -0.79%
BLRX 2.36%
BLTE -0.72%
BLU 0.03%
BLUE -0.63%
BMEA -0.29%
BMRN 0.39%
BNOX -3.57%
BNTC 2.46%
BNTX -0.16%
BOLD 0.49%
BOLT -0.50%
BPMC 0.13%
BPTH 1.26%
BPTS -13.47%
BRNS 2.96%
BRTX -9.83%
BTAI 0.75%
BTTX -7.50%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 0.00%
CABA -1.41%
CADL -0.97%
CALA 60.00%
CALC -1.62%
CALT -0.64%
CAPR -0.60%
CARA 8.02%
CARM 0.97%
CASI -2.41%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 2.61%
CCCC -2.42%
CCXI 0.00%
CDAK 0.00%
CDIO -3.01%
CDIOW 0.00%
CDMO -0.67%
CDMOP 0.04%
CDT -6.11%
CDTTW 294.32%
CDTX -0.08%
CDXC -1.18%
CDXS -1.51%
CELC 0.61%
CELU 7.05%
CELUW -9.52%
CERC -1.68%
CERE 0.19%
CERO -4.29%
CEROW -44.78%
CFRX -27.95%
CGEM -1.87%
CGEN -1.02%
CGON 1.30%
CGTX 1.37%
CHMA -6.00%
CHRS -0.20%
CINC 0.00%
CING 4.48%
CINGW -48.24%
CKPT -0.49%
CLBS -16.75%
CLDX 1.50%
CLGN 0.30%
CLLS -6.54%
CLNN 0.37%
CLNNW -41.25%
CLRB 0.74%
CLSD 0.86%
CLSN -0.68%
CLVS 0.00%
CMMB 10.18%
CMND 3.65%
CMPI 0.00%
CMPX 0.00%
CMRA 0.40%
CMRAW 33.33%
CMRX 1.11%
CNCE 0.00%
CNSP -5.00%
CNST 0.00%
CNTA 0.31%
CNTB 3.13%
CNTX -1.03%
COCP 0.42%
COEPW -0.66%
COGT -0.11%
CORT -0.28%
COYA 2.22%
CPRX -0.33%
CRBP -2.67%
CRBU -0.57%
CRDF -0.75%
CRGX 0.00%
CRIS 0.73%
CRNX -0.02%
CRSP 0.10%
CRTX 2.63%
CRVO 1.97%
CRVS 0.00%
CSBR 1.19%
CTCX -8.04%
CTIC 0.06%
CTMX 1.82%
CTNM -2.94%
CTXR 1.43%
CUE -0.75%
CVAC -2.30%
CVKD -0.12%
CWBR -2.55%
CYAD -12.96%
CYCC -2.45%
CYCCP -1.79%
CYCN 6.00%
CYT -2.27%
CYTK -0.37%
CYTO -3.23%
DARE 1.19%
DAWN 0.54%
DBTX -0.81%
DBVT 1.01%
DFFN 10.28%
DICE 0.06%
DMAC -0.42%
DNLI 1.12%
DNTH 0.04%
DOMH 1.99%
DRMA 0.00%
DRMAW 0.00%
DRNA 0.00%
DRTS -1.32%
DRTSW 1.01%
DRUG 0.00%
DSGN 0.26%
DTIL -1.19%
DYAI -5.29%
EARS -1.77%
EDIT 2.56%
EDSA 1.04%
EFTR -3.13%
EFTRW -0.26%
EIGR 0.00%
ELAB -2.87%
ELDN 0.71%
ELEV -0.84%
ELOX -12.50%
ELTX -2.33%
ELVN -0.65%
ELYM 0.52%
ENGN -3.89%
ENGNW -5.29%
ENLV 0.73%
ENOB 1.79%
ENSC 0.88%
ENTA -0.75%
ENTO 0.48%
ENTX 1.45%
ENVB 1.56%
EPIX 0.00%
EPRX -0.19%
EPZM 0.00%
EQ 1.40%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.49%
ERNA 4.79%
ERYP 1.30%
ESLA 1.14%
ESLAW -9.25%
ETNB -0.45%
ETON 1.19%
ETTX 0.00%
EVAX 4.45%
EVGN -2.55%
EVLO 50.00%
EWTX -0.58%
EXAI 0.00%
EXEL 0.00%
EYEG -0.43%
EYEN -0.33%
EYPT -1.77%
FATE -0.56%
FBIO 1.04%
FBIOP 1.09%
FBLG 0.30%
FBRX -7.46%
FDMT -0.67%
FENC 0.74%
FGEN 0.88%
FHTX 9.52%
FIXX 0.77%
FMTX 0.00%
FNCH -6.25%
FOLD -0.20%
FREQ 4.76%
FRLN 0.15%
FRTX -0.54%
FSTX 0.00%
FTRE 0.58%
FULC 0.00%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 3.20%
GANX -0.38%
GBIO 1.37%
GBT 0.01%
GDTC -7.21%
GERN -1.71%
GHRS 3.42%
GLMD -3.30%
GLPG 0.93%
GLSI -2.51%
GLTO 0.00%
GLUE 0.00%
GLYC 2.57%
GMAB 0.95%
GMDA 0.00%
GMTX 0.00%
GNCA -85.71%
GNFT 0.97%
GNLX 0.00%
GNPX 1.84%
GNTA 0.00%
GOSS 11.63%
GOVX 17.39%
GOVXW -24.72%
GPCR 0.42%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -1.42%
GRTX -4.26%
GTHX 0.38%
GUTS 0.28%
GXGXW 41.67%
GYRE 0.17%
HALO -0.01%
HARP 0.09%
HCWB -9.73%
HEPA -6.36%
HGEN -84.62%
HILS 5.66%
HLVX 0.00%
HOOK 0.56%
HOTH -3.73%
HOWL -1.27%
HRMY 0.00%
HRTX 2.64%
HSTO 62.16%
HUMA 1.52%
HUMAW -5.97%
IBRX 1.72%
ICCC 2.84%
ICPT 0.21%
ICU 1.84%
ICUCW -10.39%
ICVX -0.91%
IDRA -23.04%
IDYA -0.13%
IFRX -3.21%
IGMS 0.14%
IKNA 1.15%
IKT 8.90%
IMAB -1.10%
IMCR -1.34%
IMGN 0.02%
IMGO 0.00%
IMMP -0.37%
IMMX -0.49%
IMNM -0.46%
IMNN -0.90%
IMPL -27.27%
IMRA 15.96%
IMRN -2.78%
IMRX 0.32%
IMTX -0.38%
IMTXW -2.70%
IMUX 1.75%
IMV 0.00%
IMVT -0.11%
INAB -1.96%
INBX -0.35%
INCY 0.52%
INDP -3.03%
INFI -52.38%
INKT -0.39%
INM 1.46%
INMB -0.60%
INO 0.00%
INSM -0.87%
INTS 0.84%
INVA 1.55%
INZY 0.44%
IOBT -0.81%
IONS -0.37%
IOVA -0.49%
IPA 0.00%
IPHA -10.64%
IPSC 0.00%
IRON -1.03%
ISEE 0.38%
ITOS -0.84%
ITRM -2.61%
IVA 2.64%
IVVD 0.00%
JAGX 1.85%
JANX -0.15%
JAZZ 0.06%
JNCE 0.00%
JSPR -0.08%
JSPRW 2.33%
JUNS 0.00%
JUNSW 0%
KA -5.56%
KALV -0.42%
KDNY 0.22%
KMPH -0.34%
KNSA -0.05%
KNTE -0.38%
KOD 0.00%
KPRX 8.51%
KPTI -0.28%
KRBP 4.17%
KRON 0.00%
KROS -1.60%
KRRO -0.63%
KRTX 0.03%
KRYS -0.42%
KTRA 10.06%
KTTA -2.85%
KTTAW 8.62%
KURA 1.02%
KYMR -0.38%
KYTX 0.70%
KZIA 8.44%
KZR 0.65%
LABP 0.57%
LBPH -0.98%
LBPS 0.00%
LBPSW 14.81%
LEGN 0.19%
LENZ -1.30%
LEXX 2.73%
LEXXW -9.42%
LGND -0.46%
LGNDV 0.00%
LGVN -14.17%
LIAN 0.00%
LIFE 2.70%
LIPO -1.23%
LIXT 0.40%
LIXTW 27.74%
LJPC -0.32%
LMNL 0.12%
LOGC -0.72%
LPCN 4.72%
LPTX -0.25%
LQDA -0.23%
LRMR 1.19%
LSTA -4.97%
LTRN -2.24%
LUMO 0.00%
LVTX -1.42%
LXEO -1.05%
LXRX 0.58%
LYEL -0.45%
LYRA 0.56%
MACK 0.00%
MBIO 33.24%
MBRX -4.83%
MCRB -1.61%
MDGL 0.06%
MDNA -13.16%
MDWD 1.00%
MDXG 0.15%
MEIP 1.41%
MESO 2.07%
MGNX -2.67%
MGTA -7.74%
MGTX -1.14%
MGX 2.85%
MIRM 1.45%
MIRO 0.59%
MIST 2.96%
MITO 0.00%
MLEC -4.55%
MLECW 9.25%
MLND -5.36%
MLTX 0.09%
MLYS -0.66%
MNKD 0.00%
MNMD 1.59%
MNOV 0.00%
MNPR 3.39%
MOLN 2.88%
MOR -0.55%
MORF 1.34%
MREO 0.94%
MRKR -4.76%
MRNA -1.30%
MRNS 0.68%
MRSN 0.00%
MRTX -0.17%
MRUS -1.24%
MRVI -0.82%
MTCR -1.29%
MTEM 1.54%
MTP -18.50%
MURA -0.30%
MYMD -0.91%
NAMS 3.43%
NAMSW -7.61%
NAUT 1.17%
NBRV 0.71%
NBSE -1.56%
NBTX -6.05%
NCNA -0.17%
NERV 0.00%
NEXI -1.40%
NGM -1.28%
NGNE -3.95%
NKGN 0.78%
NKGNW 39.76%
NKTR -2.14%
NKTX -1.89%
NLSP 142.72%
NLSPW 6.21%
NMRA 1.29%
NMTR -42.97%
NOVN -24.84%
NRBO 0.45%
NRIX 4.52%
NRSN -4.95%
NRSNW 6.50%
NRXP 0.99%
NRXPW -15.65%
NRXS -6.06%
NTBL 2.92%
NTEC -12.45%
NTHI 0%
NTLA 0.00%
NTRBW -6.25%
NUVL -0.03%
NVAX -1.48%
NVCT 1.18%
NVIV -34.28%
NXTC 0.70%
NYMX -0.05%
OABI -2.08%
OABIW 13.46%
OBIO -0.87%
OBSV 0.00%
OCEA -2.99%
OCGN 2.60%
OCS -1.09%
OCUL -0.36%
OCUP 0.00%
ODT -4.27%
OKYO 0.00%
OLMA -0.47%
OMER -0.99%
OMGA 6.45%
ONCO 15.98%
ONCR -3.08%
ONCS 31.87%
ONCT -0.12%
ONCY -0.99%
ONTX -0.47%
ONVO -2.35%
OPNT 0.00%
OPT 0.80%
ORGS -1.72%
ORIC -0.13%
ORMP 0.00%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 1.54%
OVID -3.76%
OYST 0.00%
PALI 0.86%
PASG -0.99%
PBLA 9.76%
PBM -0.02%
PBYI -0.63%
PCSA 5.71%
PCVX -0.73%
PDSB -0.37%
PEPG 0.70%
PGEN 0.61%
PHAR 2.17%
PHAS 0.00%
PHAT -0.60%
PHIO 6.80%
PHIOW 36.47%
PHVS -0.53%
PHXM -5.20%
PIRS -5.64%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 0.27%
PLUR 0.00%
PMN 0.00%
PMVP 0.00%
PNT 0.16%
PPBT 2.78%
PRAX 5.56%
PRDS 0.93%
PRLD 0.77%
PROG -3.47%
PROK 1.03%
PRQR 1.18%
PRTA 0.34%
PRTC -0.72%
PRTG 6.52%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV 0.00%
PSTX 1.81%
PTCT 0.06%
PTE -0.82%
PTGX 0.03%
PTIXW 2.50%
PULM 3.72%
PXMD -1.92%
PYPD -0.36%
PYXS 0.00%
QLGN 16.48%
QNCX -1.41%
QNRX 3.04%
QSI 1.13%
QSIAW 0.00%
QTTB 0.00%
QURE -0.43%
RAIN -1.63%
RANI 0.00%
RAPT -0.30%
RARE -1.56%
RCKT 0.19%
REGN 0.06%
RENB -1.27%
REPL -0.13%
RETA 0.02%
REUN -0.89%
REVB 5.26%
REVBU 3.46%
REVBW 25.20%
RGLS 0.42%
RGNX 1.95%
RIGL 2.00%
RLAY 0.99%
RLMD 0.00%
RLYB 0.00%
RNA -1.46%
RNAC -1.07%
RNAZ 0.00%
RNXT 0.45%
ROIV 0.09%
ROIVW 4.56%
RPHM -0.60%
RPRX 0.64%
RPTX 1.58%
RUBY 2.70%
RVLP -32.05%
RVMD -0.16%
RVMDW -23.93%
RVNC 0.00%
RVPH -0.68%
RVPHW 11.54%
RXDX 0.09%
RXRX -0.11%
RYTM 0.46%
RYZB 0.02%
RZLT 1.85%
SABS -2.75%
SABSW -32.14%
SAGE 0.71%
SANA -0.17%
SAVA -0.71%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -7.25%
SCPH 0.00%
SCPS 0.00%
SEEL -1.16%
SEER -0.58%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -3.29%
SGMT -0.47%
SGTX -2.56%
SIOX 22.63%
SLDB -0.40%
SLGL -2.22%
SLN -1.55%
SLNO 0.38%
SLRX 5.16%
SLS -3.17%
SMMT -0.63%
SNDX 0.13%
SNGX 0.79%
SNPX -3.97%
SONN -4.75%
SPPI -0.49%
SPRB 0.49%
SPRC -2.02%
SPRO 3.13%
SRNE 20.00%
SRPT 0.55%
SRRA 0.00%
SRRK -0.34%
SRZN -1.70%
STAB 0.00%
STOK -0.26%
STRO 0.94%
STSA 0.00%
STTK 0.40%
SURF -0.93%
SVRA -0.78%
SWTX -3.64%
SYBX -0.63%
SYRS -2.63%
TALS -0.73%
TARA -1.16%
TARS 0.55%
TBPH 0.83%
TCBP 1.78%
TCDA 0.00%
TCON 0.74%
TCRR 0.00%
TCRT -3.13%
TCRX -1.21%
TECH 0.07%
TENX -3.43%
TERN 0.13%
TFFP -2.05%
TGTX 0.21%
THRX 0.12%
TIL -2.06%
TLC 0.00%
TLSA 0.66%
TNGX -0.16%
TNXP 0.67%
TNYA 0.00%
TPST 0.52%
TRDA -3.61%
TRVI -0.18%
TRVN 1.90%
TSHA -15.01%
TSVT 0.25%
TTNP 1.45%
TVTX -0.27%
TYRA -0.39%
UBX 0.72%
UNCY -0.11%
URGN -7.55%
UTHR 0.08%
VACC 11.36%
VALN -2.51%
VAXX -0.11%
VBIV 1.15%
VBLT -8.77%
VCEL 0.50%
VCNX -1.54%
VCYT -0.09%
VERA -0.08%
VERU 0.50%
VERV -1.33%
VIGL -2.75%
VINC 1.05%
VIR -0.87%
VIRI -5.41%
VIRX -6.84%
VKTX 0.02%
VLON -13.04%
VNDA 0.38%
VOR 0.85%
VRCA 0.00%
VRDN -0.74%
VRNA 0.06%
VRPX -14.73%
VRTX 0.06%
VSTM 0.29%
VTGN 1.46%
VTVT -0.10%
VTYX -0.36%
VXRT 6.84%
VYGR 0.10%
VYNE 2.16%
VYNT 7.78%
WINT 5.59%
WVE -0.67%
XBIO 6.75%
XBIT -0.66%
XCUR -0.65%
XENE -0.18%
XERS 0.00%
XFOR -0.54%
XLO 2.96%
XLRN 0.00%
XNCR -0.41%
XOMA 0.00%
XOMAO -0.56%
XOMAP -0.14%
XRTX 2.88%
YMAB -0.38%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -1.67%
ZNTL -25.22%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-04-15 Nisco James Sell 0 Common Stock
2016-03-23 Nisco James Sell 64 Stock Option (Right to Buy)
2018-06-02 Nisco James Sell 66 Stock Option (Right to Buy)
2019-01-25 Nisco James Sell 33 Stock Option (Right to Buy)
2016-09-29 Nisco James Sell 398 Stock Option (Right to Buy)
INSIDER POWER
76.93
Last 87 transactions
Buy: 3 444 810 | Sell: 660 832
Koreliacija (AI algo v.1.1b): Overvalued: 0.00% $3.44 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Lisata Therapeutics, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Lisata Therapeutics, Inc. Finansinės ataskaitos

Annual 2023
Pajamos: $0
Bruto pelnas: $-189 000 (0.00 %)
EPS: $-2.58
FY 2023
Pajamos: $0
Bruto pelnas: $-189 000 (0.00 %)
EPS: $-2.58
FY 2022
Pajamos: $121.37M
Bruto pelnas: $63.77M (52.54 %)
EPS: $-10.47
FY 2021
Pajamos: $0.00
Bruto pelnas: $0.00 (0.00 %)
EPS: $-1.779

Financial Reports:

No articles found.

Lisata Therapeutics, Inc. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Lisata Therapeutics, Inc. Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A
Information
First Dividend $0.250 2011-04-04
Last Dividend $0.310 2013-10-28
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 2 --
Total Paid Out $0.560 --
Avg. Dividend % Per Year 0.00% --
Score 0.22 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2026-04-06)
$0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.22
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2011 $0.250 0.01%
2012 $0 0.00%
2013 $0.310 0.03%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
28 Oct 2013 $0.310 30 Nov -0001 30 Nov -0001 30 Nov -0001
04 Apr 2011 $0.250 30 Nov -0001 30 Nov -0001 30 Nov -0001

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Diamond 2024-09-16 Monthly 14 15.03% 9.60
DMLP Dividend Diamond 2024-04-26 Quarterly 22 10.71% 9.35
OXSQ Dividend Diamond 2024-09-16 Monthly 21 12.73% 9.02
ARLP Dividend Royal 2024-05-07 Quarterly 26 9.67% 8.87
PNNT Dividend Royal 2024-06-14 Monthly 18 9.49% 8.82
MFIC Dividend Royal 2024-06-11 Quarterly 21 10.89% 8.79
SPOK Dividend Royal 2024-05-23 Quarterly 20 8.73% 8.72
PSEC Dividend Royal 2024-06-25 Monthly 21 9.03% 8.65
SBLK Dividend Royal 2024-06-06 Quarterly 17 13.10% 8.63
GBDC Dividend Royal 2024-11-29 Bi-Monthly 15 8.53% 8.62

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-0.4161.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.3971.500-5.52-8.28[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM8.920.80010.008.00[1 - 3]
quickRatioTTM8.320.80010.008.00[0.8 - 2.5]
cashRatioTTM4.091.50010.0010.00[0.2 - 2]
debtRatioTTM0.00357-1.5009.94-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM-2.272.00-0.758-1.516[0 - 30]
freeCashFlowPerShareTTM-2.272.00-1.137-2.27[0 - 20]
debtEquityRatioTTM0.00400-1.5009.98-10.00[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-109.671.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score0.382

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.5181.000-0.2540[1 - 100]
returnOnEquityTTM-0.3972.50-3.55-8.28[0.1 - 1.5]
freeCashFlowPerShareTTM-2.272.00-0.758-2.27[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-2.272.00-0.758-1.516[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.01521.500-3.430[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-1.981

Lisata Therapeutics, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.

Total Execution Time: 5.4788539409637 seconds
Number of API calls: 3
Number of DB calls: 9